Auth bypass in Zkteco Biotime
CVE-2023-51141
An issue in ZKTeko BioTime v.8.5.4 and before allows a remote attacker to obtain sensitive information via the Authentication & Authorization component
Vulnerability class: IDOR (Insecure Direct Object Reference)
Published · last modified .
CVSS v3 metric
CVSS v3 base score 6.5 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N.
EPSS exploit prediction
EPSS: 0.007 (49.5th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 50th percentile — 49.5% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.007 · newest: 0.007 · change: 0.000
Affected products
- Zkteco Biotime — versions 8.5.4
Weakness classification (CWE)
Public proof-of-concept exploits
References
- af854a3a-2127-422b-91ae-364da2661108 (Broken Link)
- af854a3a-2127-422b-91ae-364da2661108 (Permissions Required)
- gist.github.com/ipxsec/1680d29c49fe368be81b037168175b10 (Exploit, Third Party Advisory)
Frequently asked questions
- What is CVE-2023-51141?
- CVE-2023-51141 is a medium-severity vulnerability in Zkteco Biotime, classified under Authorization Bypass Through User-Controlled Key. CVSS score: 6.5/10. Published 2024-04-11.
- How severe is CVE-2023-51141?
- Medium severity. CVSS v3 base score is 6.5 out of 10.
- Is CVE-2023-51141 known to be exploited?
- 1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.